Table 1. Participant information.
| Characteristic | n | % |
|---|---|---|
| Gender | ||
| Male | 16 | 80 |
| Female | 4 | 20 |
| Age in years | ||
| Range | 18 to 70 | |
| Mean | 40 | - |
| Country of birth | ||
| Australia | 3 | 15 |
| Bangladesh | 1 | 5 |
| India | 4 | 20 |
| Indonesia | 2 | 10 |
| Myanmar | 1 | 5 |
| Nepal | 2 | 10 |
| Philippines | 2 | 10 |
| Sierra Leone | 1 | 5 |
| Vietnam | 3 | 15 |
| Zimbabwe | 1 | 5 |
| Type of tuberculosis | ||
| Pulmonary | 13 | 65 |
| Extra-pulmonary | 7 | 35 |
| Current treatment status | ||
| Intensive phase (<2 months) or isolation | 9 | 45 |
| Continuous phase (>2 months) | 10 | 50 |
| Completed treatment | 1 | 5 |
| Employment status | ||
| Retired | 3 | 15 |
| Unemployed | 2 | 10 |
| Employed and/or studying | 15 | 75 |
| Form of therapy | ||
| Clinic based directly observed therapy | 14 | 70 |
| Video directly observed therapy | 5 | 25 |
| Othera | 1 | 5 |
| Form of transport used to the TB clinic | ||
| Public transport | 6 | 30 |
| Car | 14 | 70 |
| Reported number of tablets per daily dosage (excluding completed patient) | ||
| Less than 10 tablets | 10 | 52.6 |
| More than 10 tablets | 9 | 47.4 |
a Patient previously was on clinic-based DOT but moved onto an altered treatment regimen of visiting clinic once-fortnightly and had 13 days take home supply.